1 in 10 people may have resistance to GLP1 drugs.
Stanford interviews: GLP-1 users describe quieter 'food noise', side effects and stigma
A JAMA Network Open qualitative study of 30 US adults found reduced food noise, renewed agency, side effects, stigma and access barriers.
